Dks Co. Limited · TSE:4461

Dks — Q3 FY2024 Earnings Presentation

22 slides from Dks's earnings presentation, Jan 29, 2025

  1. Slide 1: Presentation of Consolidated Financial Results for the Nine Months Ended December 31, 2024

    Presentation of Consolidated Financial Results for the Nine Months Ended December 31, 2024 of FY2024 (Fiscal Year Ending March 31, 2025) January 29, 2025 証券コード:4461(東証プライム) Securities Code: 4461 (Tokyo Stock Exchange (TSE) Prime Market) DKS Co. Ltd. 第一工業製薬株式会社 All Rights Reserved by DKS Co. Ltd.

  2. Slide 2: Today's Agenda

    Today’s Agenda 1. Consolidated Financial Results for the Nine Months Ended December 31, 2024 of FY2024 (Fiscal Year Ending March 31, 2025) P. 3 2. Consolidated Financial Results Forecasts for FY2024 (Fiscal Year Ending March 31, 2025) P.14 All Rights Reserved by DKS Co. Ltd. 2

  3. Slide 3: Consolidated Financial Results for the Nine Months Ended December 31, 2024

    1. Consolidated Financial Results for the Nine Months Ended December 31, 2024 of FY2024 (Fiscal Year Ending March 31, 2025) All Rights Reserved by DKS Co. Ltd. 3

  4. Slide 4: Overview of Financial Results (YoY)

    連結 Consolidated Overview of Financial Results (YoY) Increase in sales and profits: Demand for electronics material applications remained robust, contributing significantly to profits (Millions of yen) FY2023 FY2024 YoY Change Nine Months Nine Months (Apr.-Dec.) (Apr.-Dec.) Amount % Net sales 45,634

  5. Slide 5: Trends in Net Sales and Operating Income by Segment

    Trends in Net Sales and Operating Income 連結 Consolidated by Segment ( ): Percentage Net sales Operating income (Millions of yen) -7.1% 18.9% 617.5% (78%) -46.4% (18%) (30%) -249 -226 -226 (-23%) -249 (-47%) -194 (-5%) -93 (-18%) -260 (-7%) -605 (-61%) -519 (-14%) -691 (-130%) 2023/3 2024/3 2025/3 20

  6. Slide 6: Analysis of the Increase or Decrease in Operating Income

    Analysis of the Increase or Decrease in Operating Income for the Nine Months Ended December 31, 2024 of FY2024 *Largely reflecting the *Increase in electronics *Increase in operating *Increase in operating increase in electronics material sales volume expenses on the back of expenses owing to such m

  7. Slide 7: Consolidated Segment Results: Surfactants

    Understanding the symbols used Consolidated Segment Results: Surfactants 連結 Net sales Operating income This business has continued to provide highly functional surfactants since the Company’s founding in 1909 Net sales Operating income (Millions of yen) (Millions of yen) 6.6% -5.4% -11.0% -5.9% 2023

  8. Slide 8: Consolidated Segment Results: Amenity Materials

    Understanding the symbols used 連結 Consolidated Segment Results: Amenity Materials Net sales Operating income This business provides materials and peripheral application technologies necessary for a comfortable living environment Net sales Operating income (Millions of yen) (Millions of yen) 10.0% 0.

  9. Slide 9: Consolidated Segment Results: Polyurethane Materials

    Understanding the symbols used Segment Results: 連結 Consolidated Polyurethane Materials Net sales Operating income This business provides a variety of polyurethane raw materials, including civil engineering and construction materials, paints, adhesives, and electric insulating materials Net sales Ope

  10. Slide 10: Consolidated Segment Results: Functional Materials

    Understanding the symbols used Segment Results: 連結 Consolidated Functional Materials Net sales Operating income This business provides such products as flame retardants, radcure resins, and waterborne polyurethanes for application in home appliances and daily necessities Net sales Operating income (

  11. Slide 11: Consolidated Segment Results: Electronic Device Materials

    Understanding the symbols used Segment Results: 連結 Consolidated Electronic Device Materials Net sales Operating income This business provides such products as ceramic materials for applications in home appliances and electronic components Net sales Operating income (Millions of yen) (Millions of yen

  12. Slide 12: Consolidated Segment Results: Life Sciences

    Understanding the symbols used 連結 Consolidated Segment Results: Life Sciences Net sales Operating income This business provides naturally derived health foods and technologies for the extraction, concentration, and powdering of natural products Net sales Operating income (Millions of yen) (Millions

  13. Slide 13: Comparative Overview of Consolidated Balance Sheets

    Comparative Overview 連結 Consolidated of Consolidated Balance Sheets (Millions of yen) March 31, December 31, Increase/ 2024年 March 31, 2024年 December Increase/ 増減額 2024 2024 Decrease 3月末 2024 12月末 31, 2024 Decrease Current assets 53,614 54,298 684 Current liabilities 25,159 27,944 2,785 Notes and ac

  14. Slide 14: Consolidated Financial Results Forecasts for FY2024

    2. Consolidated Financial Results Forecasts for FY2024 (Fiscal Year Ending March 31, 2025) All Rights Reserved by DKS Co. Ltd. 14

  15. Slide 15: Consolidated Financial Results and Forecasts

    連結 Consolidated Consolidated Financial Results and Forecasts (Millions of yen) [Net sales] [Profit] -10,000 -407 -1,000 2021/3 2022/3 2023/3 2024/3 2025/3 (Revised forecasts) Operating Ordinary Net sales Profit attributable to owners of parent income income All Rights Reserved by DKS Co. Ltd. 15

  16. Slide 16: Prevailing Environment (Market Conditions)

    連結 Consolidated Prevailing Environment (Market Conditions) Area Conditions FY2024 Automobiles and ・While demand for motorcycles remains strong, slowdown in the pace of motorcycles four-wheel vehicle demand Information and ・Continued strong demand for high-end servers communication ・In addition to fi

  17. Slide 17: Net Sales Forecasts by Segment

    連結 Consolidated Net Sales Forecasts by Segment FY2023 (Results) FY2024 (Forecasts) YoY Change Segments 2H 1H 2H (Millions of yen) 1H Compo- (Results) 3Q 4Q Full FY Compo- 3Q 4Q Full FY sition (Results) (Forecasts) sition Amount (%) (%) (Forecasts) (%) Surfactants 8,809 4,862 4,857 18,529 29 9,467 5,

  18. Slide 18: Operating Income Forecasts by Segment

    連結 Consolidated Operating Income Forecasts by Segment FY2023 (Results) 2024年3月期(実績) FY2024 (Forecasts) 2025年3月期(予想) YoY Change 前期比増減 セグメント Segments 下半期 2H 下半期 2H 単位:百万円 (Millions of yen) 1H 上半期 1H 上半期 Full FY 構成比 Compo- (実績) (Results) 3Q 3Q 4Q 4Q 通期 Full FY Compo- 構成比 増減率 3Q 3Q 4Q 4Q 通期 sition (Resu

  19. Slide 19: Depreciation

    連結 Consolidated Depreciation (Millions (百万円) of yen) 4,000 3,580 3,508 3,459 3,500 3,216 3,230 3,000 2,724 2,473 2,555 2,500 2,335 2,104 2,153 2,087 2,000 1,500 1,000 500 0 2014/3 2015/3 2016/3 2017/3 2018/3 2019/3 2020/3 2021/3 2023/3 2022/3 2024/3 2025/3 2014年 2015年 2016年 2017年 2018年 2019年 2020年 2

  20. Slide 20: Capital Expenditures

    連結 Consolidated Capital Expenditures (Millions (百万円) of yen) 9,000 8,485 8,000 7,000 6,138 5,802 6,000 5,000 4,617 3,948 3,786 4,000 3,172 2,467 2,724 3,000 1,925 1,854 2,000 1,512 1,000 0 2014/3 2015/3 2016/3 2017/3 2018/3 2019/3 2020/3 2021/3 2022/3 2023/3 2024/3 2025/3 2014年 2015年 2016年 2017年 201

  21. Slide 21: R&D Costs

    連結 Consolidated R&D Costs (Millions (百万円) of yen) 4,000 3,555 3,500 3,236 3,170 2,946 3,000 2,765 2,748 2,821 2,506 2,439 2,380 2,393 2,307 2,500 2,000 1,500 1,000 500 0 2014/3 2015年 2016/3 2015/3 2016年 2017/3 2018/3 2019年 2021/3 2020/3 2021年 2019/3 2020年 2022/3 2023/3 2024/3 2025/3 2014年 2017年 2018

  22. Slide 22: Disclaimer Regarding Earnings Forecasts and Business Plans

    Disclaimer Regarding Earnings Forecasts and Business Plans This presentation contains such information as the Company’s current plans and earnings forecasts. These forward-looking statements, including future plans and forecasts are based on currently available information. Actual results may differ

DKS — Q3 FY2024 Earnings Presentation on 6ix